1. Home
  2. KE vs CADL Comparison

KE vs CADL Comparison

Compare KE & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kimball Electronics Inc.

KE

Kimball Electronics Inc.

HOLD

Current Price

$24.56

Market Cap

586.4M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$10.02

Market Cap

694.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KE
CADL
Founded
1961
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
586.4M
694.6M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
KE
CADL
Price
$24.56
$10.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$28.00
$19.00
AVG Volume (30 Days)
215.1K
2.0M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
0.78
N/A
Revenue
$1,486,727,000.00
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.57
N/A
P/E Ratio
$31.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.04
$4.35
52 Week High
$33.19
$11.36

Technical Indicators

Market Signals
Indicator
KE
CADL
Relative Strength Index (RSI) 46.59 57.11
Support Level $23.65 $4.80
Resistance Level $26.87 $11.36
Average True Range (ATR) 1.07 0.61
MACD -0.04 -0.04
Stochastic Oscillator 39.12 64.29

Price Performance

Historical Comparison
KE
CADL

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: